日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation

构建抗体武装溶瘤病毒:设计策略、协同机制和临床转化

Kang, Xiaozhen; Yang, Xue; Wu, Hui; Tong, Xiangmin; Wang, Shibing

IL-18-armed oncolytic vaccinia virus remodels the suppressive microenvironment via macrophage and Treg modulation in lymphoma

IL-18 武装的溶瘤痘苗病毒通过调节巨噬细胞和 Treg 细胞重塑淋巴瘤的抑制性微环境

Wu, Hui; Zhang, Jiaqing; Xu, Li; Xie, Yifan; Pan, Lingli; Zhang, Xinyue; Xia, Yongming; Yang, Fang; Kang, Xiaozhen; Tong, Xiangmin; Wang, Shibing

An oncolytic vaccinia virus encoding CD47 nanobody potentiates antitumor immunity in multiple myeloma.

编码 CD47 纳米抗体的溶瘤痘苗病毒可增强多发性骨髓瘤的抗肿瘤免疫力。

Pan Lingli, Zhu Xiaomeng, Zhang Jiaqing, Zhong Qingyao, Wu Hui, Sun Weidong, Xia Yongming, Wang Shibing, Tong Xiangmin

Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

作者更正:4-1BB共刺激CD19特异性CAR-NK细胞疗法治疗难治性/复发性大B细胞淋巴瘤的安全性和可行性:一项I期试验

Lei, Wen; Liu, Hui; Deng, Wenhai; Chen, Wei; Liang, Yun; Gao, Wenxia; Yuan, Xianggui; Guo, Shanshan; Li, Ping; Wang, Jinyong; Tong, Xiangmin; Sun, Yi Eve; Liang, Aibin; Qian, Wenbin

Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

4-1BB共刺激CD19特异性CAR-NK细胞疗法治疗难治性/复发性大B细胞淋巴瘤的安全性和可行性:一项I期试验

Lei, Wen; Liu, Hui; Deng, Wenhai; Chen, Wei; Liang, Yun; Gao, Wenxia; Yuan, Xianggui; Guo, Shanshan; Li, Ping; Wang, Jinyong; Tong, Xiangmin; Sun, Yi Eve; Liang, Aibin; Qian, Wenbin

Synergistic tumor microenvironment modulation enabled by a nanozyme-boosted biomimetic macrophage-derived nanovesicle for highly efficient antitumor therapy

纳米酶增强的仿生巨噬细胞衍生纳米囊泡可协同调节肿瘤微环境,从而实现高效抗肿瘤治疗

Su, Yue; Wu, Haibin; Duan, Ke; Xie, Jiahao; Huang, Weitao; Mou, Xiaozhou; Ye, Xiangming; Shen, Yeyu; Li, Ting; He, Junjia; Fu, Luoqin; Wang, Yin; Wen, Liping; Bian, Qiong; Zhu, Mingang; Tong, Xiangmin

DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target

DHODH介导的线粒体氧化还原稳态:一种新型铁死亡调节因子和有前景的治疗靶点

Cao, Jinghao; Chen, Xi; Chen, Lulu; Lu, Yajuan; Wu, Yunyi; Deng, Aoli; Pan, Feifan; Huang, Hangqi; Liu, Yingchao; Li, Yanchun; Tong, Xiangmin; Du, Jing

Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death

铁氧还蛋白:线粒体氧化还原稳态和程序性细胞死亡的关键调节因子

Lu, Yajuan; Wu, Yunyi; Yang, Chen; Zhou, Yi; Ren, Xueying; Li, Haoran; Huang, Hangqi; Pan, Feifan; Deng, Aoli; Lu, Yi; Yang, Jiayi; Tong, Xiangmin; Li, Yanchun; Du, Jing

Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma

负载溶瘤痘苗病毒/IR1061的苦参来源细胞外囊泡用于近红外二区光声成像引导的多模式治疗弥漫性大B细胞淋巴瘤

Ji, Lichen; Huang, Jiaqing; Kang, Yehui; Wu, Chao; Chen, Yang; Wu, Yanfang; Zheng, Xiaoyan; Tong, Xiangmin; Yin, Feng; Cai, Yu; Shao, Yinyan

Epitranscriptomic modifications in programmed cell death: mechanistic insights and implications for liver diseases

程序性细胞死亡中的表观转录组修饰:机制解析及其对肝脏疾病的影响

Chen, Lulu; Lu, Yajuan; Deng, Aoli; Cao, Jinghao; Jin, Feifan; Huang, Hangqi; Pan, Feifan; Liu, Yingchao; Li, Yanchun; Tong, Xiangmin; Yao, Hongfeng; Du, Jing